Literature DB >> 1100296

Tardive dyskinesia as a possible sequel of long-term therapy with phenothiazines.

G W Paulson, C A Rizvi, G E Crane.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1100296     DOI： 10.1177/000992287501401013

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN： 0009-9228            Impact factor:   1.168


× No keyword cloud information.
  5 in total

1.  Prevalence of movement disorders in adolescent patients with schizophrenia and in relationship to predominantly atypical antipsychotic treatment.

Authors:  Stefan Gebhardt; Fabian Härtling; Markus Hanke; Markus Mittendorf; Frank M Theisen; Karin Wolf-Ostermann; Phillip Grant; Matthias Martin; Christian Fleischhaker; Eberhard Schulz; Helmut Remschmidt
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-04-28       Impact factor: 4.785

Review 2.  Environmental effects on the central nervous system.

Authors:  G W Paulson
Journal:  Environ Health Perspect       Date:  1977-10       Impact factor: 9.031

3.  Tardive dyskinesia and pregnancy and delivery complications.

Authors:  M H El-DeFrawi; G Hirsch; A Jurkowicz; T J Craig
Journal:  Child Psychiatry Hum Dev       Date:  1996

Review 4.  Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors.

Authors:  Nicki Niemann; Joseph Jankovic
Journal:  Drugs       Date:  2018-04       Impact factor: 9.546

Review 5.  Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia.

Authors:  Hanna Bergman; John Rathbone; Vivek Agarwal; Karla Soares-Weiser
Journal:  Cochrane Database Syst Rev       Date:  2018-02-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.